X4 Pharmaceuticals (XFOR) Total Liabilities (2018 - 2025)
Historic Total Liabilities for X4 Pharmaceuticals (XFOR) over the last 8 years, with Q3 2025 value amounting to $101.9 million.
- X4 Pharmaceuticals' Total Liabilities fell 1401.0% to $101.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.9 million, marking a year-over-year decrease of 1401.0%. This contributed to the annual value of $124.3 million for FY2024, which is 2926.3% up from last year.
- Per X4 Pharmaceuticals' latest filing, its Total Liabilities stood at $101.9 million for Q3 2025, which was down 1401.0% from $101.2 million recorded in Q2 2025.
- In the past 5 years, X4 Pharmaceuticals' Total Liabilities ranged from a high of $124.3 million in Q4 2024 and a low of $49.9 million during Q1 2022
- For the 5-year period, X4 Pharmaceuticals' Total Liabilities averaged around $84.5 million, with its median value being $96.2 million (2023).
- As far as peak fluctuations go, X4 Pharmaceuticals' Total Liabilities skyrocketed by 10779.65% in 2023, and later plummeted by 1401.0% in 2025.
- X4 Pharmaceuticals' Total Liabilities (Quarter) stood at $52.8 million in 2021, then skyrocketed by 54.53% to $81.5 million in 2022, then rose by 17.94% to $96.2 million in 2023, then rose by 29.26% to $124.3 million in 2024, then fell by 17.99% to $101.9 million in 2025.
- Its last three reported values are $101.9 million in Q3 2025, $101.2 million for Q2 2025, and $107.1 million during Q1 2025.